Compare VC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VC | OGN |
|---|---|---|
| Founded | 2000 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2000 | N/A |
| Metric | VC | OGN |
|---|---|---|
| Price | $103.96 | $7.16 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 5 |
| Target Price | ★ $129.08 | $14.10 |
| AVG Volume (30 Days) | 311.9K | ★ 4.8M |
| Earning Date | 10-23-2025 | 11-10-2025 |
| Dividend Yield | 1.06% | ★ 1.11% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 11.17 | 1.91 |
| Revenue | $3,759,000,000.00 | ★ $6,301,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.92 | N/A |
| P/E Ratio | $9.33 | ★ $3.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $65.10 | $6.18 |
| 52 Week High | $129.10 | $17.23 |
| Indicator | VC | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 50.81 | 43.82 |
| Support Level | $98.57 | $6.90 |
| Resistance Level | $103.38 | $7.49 |
| Average True Range (ATR) | 2.48 | 0.30 |
| MACD | 0.73 | 0.03 |
| Stochastic Oscillator | 72.42 | 25.65 |
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.